Key result
Awareness of the reason for warfarin use was a strong independent predictor of achieving adequate anticoagulation control (TTR ≥70%) with an OR of 1.699.
Why the study?
What are the independent predictors of adequate anticoagulation control (TTR ≥70%) in patients treated with warfarin?
Observational (n=4,987)
Yes
What are the independent predictors of adequate anticoagulation control (TTR ≥70%) in patients treated with warfarin?
A low proportion of patients taking warfarin achieve adequate TTR, and patient awareness of warfarin use and interactions is a strong independent predictor of adequate control.
Awareness of warfarin indication may aid TTR control; hypothesis-generating for education trials before practice change.
Background: In the present study, we aimed to evaluate the factors that might be caused by adequate anticoagulation control in patients treated with warfarin for any reason. Methods: The WARFARIN-TR (The Awareness, Efficacy, Safety, and Time in Therapeutic Range of Warfarin in Turkish Population) study included 4987 patients using warfarin between January 1, 2014 and December 31, 2014. Time in therapeutic range (TTR) was calculated according to F. R. Roosendaal's algorithm with linear interpolation. The study population divided into two groups; adequate international normalized ratio (INR) control when TTR ≥70% (Group 1, n = 1068, 21.4%) and inadequate INR control when TTR <70% (Group 2, n = 3919, 78.6%). All demographic and clinic characteristics of the patients were compared to determine possible factors that might be cause adequate warfarin use. Results: The mean age of the study population was 60.7 ± 13.5 years, and there was no significant difference between groups. The mean TTR value of Group 1 was significantly higher than Group 2 (80 ± 8.5 vs. 40.9 ± 17.2; P < 0.001). The traditional cardiovascular risk factors were similar between groups except hypertension (Group 1 51.4% and Group 2 56.4%; P = 0.004) and chronic kidney disease (Group 1 8.3% and Group 2 5.5%; P = 0.001). There were no significant differences between groups regarding bleeding. The awareness of warfarin use was significantly higher in Group 1 patients than Group 2 patients. Multivariate logistic regression analysis revealed that age (odds ratio [OR], 1.007; P = 0.014), hypertension (OR, 0.821; P = 0.01), atrial fibrillation (OR, 1.180; P = 0.033), chronic kidney disease (OR, 1.697; P < 0.001), to know warfarin use reason (OR, 1.699; P < 0.001), and know to food-drug interaction with warfarin (OR, 1.583; P < 0.001) were independent predictors of adequate coagulation. Conclusion: Our study demonstrated that a low proportion of patients taking warfarin achieve an adequate TTR in daily practice. Furthermore, the patients with adequate TTR are more aware of warfarin use.
No takes yet. Share an insight, caveat, or question.
Kılıç et al. (2018) conducted an observational in Patients treated with warfarin (n=4,987). Warfarin vs. Inadequate INR control (TTR <70%) was evaluated on Adequate anticoagulation (TTR ≥70%) predicted by knowing warfarin use reason (OR 1.699, 95% CI 1.341-2.153, p=<0.001). Awareness of the reason for warfarin use was a strong independent predictor of achieving adequate anticoagulation control (TTR ≥70%) with an OR of 1.699.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: